Cogent Biosciences, Inc.
← Back to COGT Overview

Cogent Biosciences, Inc. (COGT)

Solvency & Capital Structure

Total Debt

$238.7M

Net Debt

-$627.7M

Cogent Biosciences, Inc. currently has $238.7M in total debt. Net debt is -$627.7M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

COGTQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-310.240.87-0.63Net Cash0.9026.4%
2025-12-310.250.90-0.65Net Cash0.9427.0%
2025-09-300.060.39-0.33Net Cash0.4314.2%
2025-06-300.060.24-0.18Net Cash0.2722.1%
2025-03-310.020.25-0.23Net Cash0.286.0%
2024-12-310.020.29-0.27Net Cash0.335.3%
2024-09-300.020.34-0.32Net Cash0.384.6%
2024-06-300.020.36-0.35Net Cash0.434.2%
2024-03-310.020.44-0.42Net Cash0.483.9%
2023-12-310.020.27-0.25Net Cash0.316.0%
2023-09-300.020.28-0.26Net Cash0.365.4%
2023-06-300.020.33-0.31Net Cash0.394.9%
2023-03-310.020.22-0.20Net Cash0.267.4%
2022-12-310.020.26-0.24Net Cash0.306.5%
2022-09-300.020.29-0.27Net Cash0.336.1%
2022-06-300.030.33-0.30Net Cash0.377.7%
2022-03-310.000.19-0.19Net Cash0.211.7%
2021-12-310.000.22-0.22Net Cash0.231.4%
2021-09-300.000.20-0.20Net Cash0.221.7%
2021-06-300.000.22-0.21Net Cash0.231.8%
2021-03-310.000.23-0.23Net Cash0.242.0%
2020-12-310.010.24-0.24Net Cash0.252.1%
2020-09-300.010.13-0.12Net Cash0.144.1%
2020-06-300.010.02-0.02Net Cash0.0316.9%
2020-03-310.010.03-0.02Net Cash0.0414.5%
2019-12-310.010.04-0.03Net Cash0.0512.2%
2019-09-300.010.05-0.04Net Cash0.0611.1%
2019-06-300.010.06-0.05Net Cash0.079.8%
2019-03-310.010.07-0.06Net Cash0.088.8%
2018-12-310.000.08-0.08Net Cash0.090.0%
2018-09-300.000.09-0.09Net Cash0.090.0%
2018-06-300.000.09-0.09Net Cash0.100.0%
2018-03-310.000.03-0.03Net Cash0.040.0%
2017-12-310.000.04-0.04Net Cash0.050.0%
2017-09-300.000.05-0.05Net Cash0.060.0%
2016-09-300.050.010.040.3116.0%
Cogent Biosciences, Inc. (COGT) Debt History — Total Debt & Net Debt Analysis